Impact of saffron as an anti-cancer and anti-tumor herb

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 11, 2010, Pages 834-840

  Chermahini, Siavash Hosseinpour ^a   Majid, Fadzilah Adibah Abd ^a   Sarmidi, Mohamad Roji ^a   Taghizadeh, Ehsan ^b   Salehnezhad, Saleh ^b  

^a UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Chemoprevention; Tumor bearing; Volatile

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CYSTEINE; SAFFRON; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; DRUG DETERMINATION; DRUG MECHANISM; EHRLICH ASCITES TUMOR; EHRLICH ASCITES TUMOR CELL; NEPHROTOXICITY; NONHUMAN; SKIN CANCER;

EID: 78650986873     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Abdullaev FI, Cabalerro-Ortega H, Riveron-Negrete L, Pereda-Miranda R, Rivera-Luna R, Hernandez JM, Perez-Lopez I, Espinosa-Aguirre JJ (2003). Evaluacion in vitro del potencial quimiopreventivi del azafran. Revista de Investigacion Clinica, 54: 430-436.
2. Abdullaev FI, Frenkel GD (1992b). The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells. BioFactors, 4: 43-45.
3. Abdullaev FI, Frenkel GD (1999). Saffron in biological and medical research. In: Negbi M, Ed. Saffron Crocus sativus L. Amsterdam: Harwood Acad. Publishers, 103-113.
4. Abdullaev FI, Frenkel GD (1992a). Effect of saffron on cell colony formation and cellular nucleic acid and protein synthesis. BioFactors, 3: 201-204.
5. Abdullaev FI, Gonzalez de Mejia E (1997). Actividad antitumoral de compuestos naturales: lectinas y azafran. Arch Latinoam Nutr., 47: 195-202.
6. Abdullaev FI, Gonzalez ME (1997). Antitumor effect of plant lectins. Natl Toxins, 5: 57-163.
7. Abdullaev FI, Gonzalez ME (1995/1996). Inhibition of colony formation of Hela cells by naturally occurring and synthetic agents. BioFactors, 5(3):133-138.
8. Abdullaev FI, Rivera LR, Roitenburd BV, Espinosa AJ (2000). Pattern of childhood cancer mortality in Mexico. Arch Med Res., 31(5): 526- 531.
9. Abdullaev FI, Riveron NL, Cabalerro-OH, Hernandez JM, Perez LI, Pereda-Miranda R, Espinosa-Aguirre JJ (2003b). Use of in vitro assays to assess the antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.) Toxicol. In Vitro, 17: 731-736.
10. Abdullaev FI (1993). Biological effects of saffron. BioFactors, 4(2): 83- 86.
11. Abdullaev FI (1994). Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett., 40: 243- 251.
12. Abdullaev FI (2001). Plant-derived agents against cancer. In: Gupta SK, Ed. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House, pp. 345-354.
13. Abdullaev F (2002). Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med., 227: 20-25.
14. Abdullaev JF, Espinosa-Aguirre JJ (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials, Cancer Detection Prev., 28(6): 430-436.
15. Abe K, Saito H (2000). Effects of saffron extract and its constituent crocin on learning behavior and long-term Potentiation, Phytother Res., 14: 149-52.
16. Akhondzadeh S et al (2004). Comparison of Crocus sativus and Chermahini et al.839 imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial, Biomed Central Complementary Alternative Med., 4.
17. Akhondzadeh S et al (2005). Crocus sativus in the treatment of mild to moderate depression: a double-blind, randomized and placebo- controlled trial, Phytotherapy Res., 19: 148-151.
18. Alonso GL, Salinas MR, Esteban-Infantes FJ, Sánchez-Fernández MA (1996). Determination of safranal from saffron (Crocus sativus L.) by thermal desorption-gas chromatography. J. Agric. Food Chem., 44: 185-188.
19. Alonso GL, Salinas MR, Garijo J (1998). Method to determine the authenticity of aroma of saffron (Crocus sativus L.). J. Food Prot., 61: 1525-1528.
20. Basker D, Negbi M (1983). The use of saffron. Econ Bot., 37: 228-236.
21. Castellar MR, Montijano H, Manjón A, Iborra JL (1993). Preparative high-performance liquid chromatographic purification of saffron secondary metabolites. J. Chromatogr., 648: 187-190.
22. Chang PY, Wang CK, Liang CT, Kuo W (1964). The pharmacological action of Zang Hong Hua (Crocus sativus L.): effect on the uterus and/or strous cycle. Yao Hsueh Hsueh Pao, 11: 94-100.
23. Chang VC, Lin YL, Lee MJ, Show SJ, Wang CJ (1996). Inhibitory effect of crocetin on benzo(a)pyrece genotoxicity and neoplastic transformation in C3H1OT1/2 cells. Anticancer Res 765: 3603-3608.
24. Corti P, Mazzei E, Ferri S, Franchi GG, Dreassi E (1996). High-performance thin layer chromatographic quantitative analysis of picrocrocin and crocetin, active principles of saffron (Crocus sativus L.-Iridaceae): a new method. Phytochem. Anal., 7: 201-203.
25. Curró C, Micgelli G (1979). Determinazione specttrofotometrica del potere colorante, Americane ed odoroso dello zafferano. Boll Chim. Farm, 118: 553-562.
26. Dufresne C, Cormier F, Dorion S (1997). In vitro formation of crocetin glucosyl esters by Crocus sativus callus extract. Planta Med., 63: 150-153.
27. Duke JA (1998). Handbook of Medicinal Herbs. Boca Raton, Florida: CRC Press el Daly ES. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J. de Pharmacie de Belgique, 53: 9395.
28. Eisenberg D, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993). Unconventional medicine in the United States: prevalence, cost and patterns of use. N Engl. J. Med., 328: 246-252.
29. Garcia-Olmo DC (1999). Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus): an experimental study in the rat, Nutr. Cancer, 35: 120-126.
30. Gresta F, Lombardo GM, Siracusa L, Ruberto G (2008). Saffron, an alternative crop for sustainable agricultural systems. A review. Agron. Sustain. Dev., 28: 95-112.
31. Grisolia S (1974). Letter: hypoxia, saffron, and cardiovascular disease. Lancet, 2(7871):41-42.
32. Hadizadeh F, Mahdaci M, Emami SA, Khashayarmanesh Z, Hassanzadeh M, Asili J, Seifi M, Nassiri H, Shariatimoghadam A, Noorbakhsh R (2007). Evaluation of ISO method in saffron quantification. In: Koosheki, Nassiri, Ghorbani, (Eds.), Proceedings of the second international Symposium on Saffron. Biology and Technology, Acta Hortic. (ISHS), 739: 405-410.
33. Himeno H, Sano K (1987). Synthesis of crocin, picrocrocin and safranal by saffron stigma-like structures proliferated in vitro. Agric. Biol. Chem., 51(9): 2395-2400.
34. Hosseinzadeh H, Khosravan V (2002). Anticonvulsant effects aqueous and ethanolic extracts of Crocus sativus stigmas in mice, Archives Iranian Med., 5: 44-47.
35. Iborra JL, Castellar MR, Cánovas M, Manjón A (1993). Analysis of a packed-bed reactor for hydrolysis of picrocrocin by immobilized ß- glucosidase. Enzyme Microb Technol., 15: 780-784.
36. Iborra JL, Castellar MR, Cánovas M, Manjón A (1992). TLC preparative purification ofpicrocrocin, HTCC and crocin from saffron. J. Food Sci., 3: 714-716.
37. Kubo I, Kinst HI (1999). Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. J. Agric. Food Chem., 47(10): 4121-4125.
38. Lage M, Cantrell CL (2009). Quantification of saffron (crocus sativus l.) metabolites crocins, picrocrocin and safranal for quality determination of the spice grown under differentenvironmental Moroccan 840Afr. J. Pharm. Pharmacol. conditions. Scientia Horticulturae, 121: 366-373.
39. Li N, Lin G, Kwan YW, Min D (1999). Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography. J. Chromatogr. A, 849(2): 349-355.
40. Lozano P, Castellar MJ, Simancas MJ, Iborra JL (1999). Quantitative high-performance liquid chromatographic method to analyze commercial saffron (Crocus sativus L.) products. J Chromatogr. A, 830: 477-483.
41. Morjani H, Tarantilis P, Polissiou M, Manfait M (1990). Growth inhibition and induction of crythroid differentiation activity by crocin, dimethylcrocetine and ß-carotene on K562 tumor cells. Anticancer Res., 10: 1398-1406.
42. Nadkarni KM (1976). Crocus sativus, Nigella sativa. In: Nadkarni KM, Ed. Indian Materia Medica, Bombay: Popular Prakashan, pp. 386-411.
43. Nair SC, Kurumboor SK, Hasegawa JH (1995).Saffron chemopreven- tion in biology and medicine: a review. Cancer Biother., 10(4): 257-264.
44. Nair SC, Pannikar B, Pannikar KR (1991). Antitumour activity of saffron (Crocus sativus). Cancer Lett., 57(2): 109114.
45. Nair SC, Salomi MJ, Pannikar. B, Pannikar KR (1991). Modulatory effects of the extracts of saffron and Nigela sativa against cisplatinum induced toxicity in mice. J. Ethnopharmacol., 31: 75-83.
46. Nair SC, Salomi MJ, Varghese CD, Pannikar B, Pannikar KR (1992). Effect of saffron on thymocyte proliferation, intracellular gluthathione levels and its antitumor activity. BioFactors, 4(1): 5154.
47. Nair SC, Varghese CD, Pannikar KR, Kurumboor SK, Parathod RK. (1994). Effects of saffron on vitamin A levels and its antitumor activity on the growth of solid tumors in mice. Int. J. Pharmacog., 32(2): 105-114.
48. Narasimhan H, Chand H, Rajalakshmi D (1992). Saffron, quality evaluation by sensory profile and gas chromatography. J. Food Qual., 15: 303-314.
49. Negbi M (1999). Saffron cultivation: past, present and future prospects. In: Negbi M, Ed. Saffron Crocus sativus L. Amsterdam: Harwood Academic Publishers. pp. 1-19.
50. Noorbala AA (2005). Hydro-alcoholic extract of Crocus sativus versus fluoxetine in the treatment of mild to moderate depression: a double- blind, randomized pilot trial, J. Ethnopharmacol., 97(2): 281-284
51. Oberdieck R (1991). Ein beitrag zur kenntnis und analytik von safran (Crocus sativus L.). Deutshe Lebensmittel Rundschau, 87(8): 246- 252.
52. Oda Y, Tatsumi Y (1993). New lectins from bulbs of Crocus sativus. Biol. Pharm. Bull., 16(10): 978-981.
53. Palozza P, Krinsky NI (1992). Antioxidant effects of carotenoids in vivo and in vitro: an overview. Methods Enzymol. 213: 403-420.
54. Pfander H, Schurtenberge H (1982).Biosynthesis of C20-carotenoids in Crocus sativus. Phytochem., 21: 1039-1042.
55. Rios JL, Recio MC, Giner RM, Mañez S (1996). An update review of saffron and its active compounds. Phytother. Res., 10(3): 189-193.
56. Riverón-Negrete L,and others (2002).The combination of natural and synthetic agents: a new pharmacological approach in cancer chemoprevention. Procedures Western Pharmacol. Society, 45: 74- 75.
57. Rödel W, Petrzika M (1991). Analysis of the volatile components of saffron. J. High Res. Chromatogr., 14: 771-774.
58. Saito K, Utsumi Y (1996). Enhancing effect of UV light on accumulation of carthamine in dyer's saffron florets. Z Naturfosch, [C] 51(9-10): 667-670.
59. Salomi MJ, Nair SC, Panikkar PR (1991). Cytotoxicity and non- mutagenicity of Nigela sativa and saffron (Crocus sativus) in vitro.Proc. Ker. Sci. Congr., 5: 244.
60. Salomi MJ, Nair SC, Panikkar PR (1990). Inhibitory effects of Nigela sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice and its non-mutagenic activity. Proc. Ker. Sci. Congr., 3: 125-126.
61. Salomi MJ, Nair SC, Panikkar PR (1991). Inhibitory effects of Nigela sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr. Cancer, 16(1): 67-72.
62. Selim K, Tsimidou M, Biliaderis CG (2000). Kinetic studies of degradation of saffron carotenoids encapsulated in amorphous polymer matrices. Food Chem., 71(2): 199-206.